CAMERON PHARMACEUTICALS, LLC
LOUISVILLE, KY

Cameron Pharmaceuticals, LLC is a Florida-based pharmaceutical company with a comprehensive range of services catering to both niche brand and generic pharmaceutical markets. Founded in 2014 by seasoned executives John McMahon and Mike Venters, the company leverages over four decades of combined experience in commercial operations, trade contracting, and sales, among other areas, to navigate today’s competitive environment successfully. Cameron Pharmaceuticals not only focuses on in-licensing and developing pharmaceutical products for sale under its own label but also extends partnership opportunities to other small pharmaceutical companies. Through its entity Pharma Trading Partners (PTP), Cameron offers administrative, financial services support, and can handle the order-to-cash process for partnered firms using its established commercial platform. The company has a strong history of addressing market needs that arose post the Affordable Care Act era, particularly among start-up pharmaceutical entities lacking marketing capabilities. Both founders began with Macoven Pharmaceuticals, which demonstrated rapid growth under their management before being acquired in 2010. Their subsequent roles further solidified Cameron's expertise and trustworthiness in trade positioning for both generic and brand pharmaceuticals. With a leadership team featuring individuals like Tracy Clifford (CFO), Anand Rai (VP of Business Development), John McMahon, and Mike Venters, Cameron Pharmaceuticals brings an integrated approach to business development, commercial oversight, financial management, sales, and marketing strategies. The company is registered in Florida under the status 'Active', with its main office located at 12305 Westport Rd., Suite 205, Louisville, KY 40245. The contact number for Cameron Pharmaceuticals is (888) 767-7913, with additional information available on their website, cameronpharmaceuticals.com. As demonstrated by the latest annual report dated April 10, 2024, Cameron continues to be a dynamic force in pharmaceutical commercialization and consultancy.